143 filings
Page 3 of 8
8-K
2t4ednlrm
22 Mar 22
Entry into a Material Definitive Agreement
8:00am
8-K
lqm1ifb9jfd2tgn9 nv
10 Mar 22
Selecta Biosciences Reports Fourth Quarter and Full Year 2021 Financial Results
8:00am
8-K
x3v3fwps
16 Feb 22
February 2022 Selecta Biosciences Corporate Presentation SELB
8:00am
8-K
wwfx30a0ncgxn3034 eb
10 Feb 22
Other Events
8:00am
8-K
2u7tazuj9klx29q22qld
10 Jan 22
Other Events
7:05am
8-K
xha20
24 Nov 21
Selecta Biosciences Provides Update on Phase 1/2 Clinical Trial of SEL-302 for the Treatment of
4:22pm
8-K
7u9qld6a29u7hvg7n
9 Nov 21
Selecta Biosciences Reports Third Quarter 2021 Financial Results and Provides Business Update
8:00am
8-K
aekymfjhzoyx58o 9y
8 Nov 21
Regulation FD Disclosure
8:06am
8-K
71nlq4nrddv7cu 06i
26 Oct 21
Other Events
8:00am
8-K
kah rhwy0xc5s
25 Oct 21
Entry into a Material Definitive Agreement
8:06am
8-K
9uxkwa
21 Oct 21
Other Events
8:00am
8-K
x1fjh
4 Oct 21
Other Events
8:00am
8-K
6p2aukmm94
30 Sep 21
Amendments to Articles of Incorporation or Bylaws
8:00am
8-K
q26jc
20 Sep 21
Departure of Directors or Certain Officers
8:00am
8-K
khg7jspb 8b
8 Sep 21
Other Events
8:05am
8-K
ijbzalx69okw2y
12 Aug 21
Selecta Biosciences Reports Second Quarter 2021 Financial Results and Provides Business Update
9:04am
8-K
auob6cb2l
24 Jun 21
Departure of Directors or Certain Officers
8:15am
8-K
0i64sq9j
21 Jun 21
Submission of Matters to a Vote of Security Holders
4:31pm
8-K
sn181i2qkojf
13 May 21
Selecta Biosciences Reports First Quarter 2021 Financial Results and Provides Business Update
8:01am
8-K
wh45l3f3w2zq
29 Apr 21
Selecta Biosciences and AskBio Announce Updates to Methylmalonic Acidemia (MMA-101) Program
9:04am